HomeCompareEMCF vs MRK

EMCF vs MRK: Dividend Comparison 2026

EMCF yields 68.61% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMCF wins by $159.72M in total portfolio value
10 years
EMCF
EMCF
● Live price
68.61%
Share price
$31.60
Annual div
$21.68
5Y div CAGR
22.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$159.78M
Annual income
$115,005,568.27
Full EMCF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — EMCF vs MRK

📍 EMCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMCFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMCF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMCF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMCF
Annual income on $10K today (after 15% tax)
$5,831.65/yr
After 10yr DRIP, annual income (after tax)
$97,754,733.03/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, EMCF beats the other by $97,746,136.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMCF + MRK for your $10,000?

EMCF: 50%MRK: 50%
100% MRK50/50100% EMCF
Portfolio after 10yr
$79.92M
Annual income
$57,507,841.02/yr
Blended yield
71.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EMCF
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMCF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMCFMRK
Forward yield68.61%2.81%
Annual dividend / share$21.68$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR22.1%32.7%
Portfolio after 10y$159.78M$57.7K
Annual income after 10y$115,005,568.27$10,113.78
Total dividends collected$155.59M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EMCF vs MRK ($10,000, DRIP)

YearEMCF PortfolioEMCF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$19,077$8,376.99$11,213$373.04+$7.9KEMCF
2$38,648$18,236.00$12,667$512.06+$26.0KEMCF
3$83,512$42,158.28$14,439$708.14+$69.1KEMCF
4$193,310$103,951.94$16,640$988.16+$176.7KEMCF
5$481,422$274,580.27$19,432$1,394.07+$462.0KEMCF
6$1,295,442$780,320.52$23,057$1,992.90+$1.27MEMCF
7$3,782,179$2,396,056.69$27,889$2,894.79+$3.75MEMCF
8$12,029,694$7,982,762.21$34,518$4,286.29+$12.00MEMCF
9$41,845,044$28,973,271.57$43,912$6,494.35+$41.80MEMCF
10$159,779,766$115,005,568.27$57,714$10,113.78+$159.72MEMCF

EMCF vs MRK: Complete Analysis 2026

EMCFStock

Emclaire Financial Corp operates as the bank holding company for The Farmers National Bank of Emlenton that provides retail and commercial financial products and services to individuals and businesses in western Pennsylvania. The company's deposit products include checking, savings, and term certificate accounts; savings and time deposits; non-interest bearing and interest-bearing demand deposit accounts; and money market accounts. Its loan portfolio comprises one-to-four family mortgage loans, home equity loans, commercial business and commercial real estate loans, consumer loans, and loans to one borrower. The company operates a network of 19 retail branch offices in Venango, Allegheny, Butler, Clarion, Clearfield, Crawford, Elk, Jefferson, and Mercer counties, and Pennsylvania. The company was founded in 1900 and is headquartered in Emlenton, Pennsylvania.

Full EMCF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EMCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMCF vs SCHDEMCF vs JEPIEMCF vs OEMCF vs KOEMCF vs MAINEMCF vs JNJEMCF vs ABBVEMCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.